- Q4 2023 Phathom Pharmaceuticals Inc Earnings Call TranscriptMar 07, 2024$9.09 (-6.58%)Earnings
- Phathom Pharmaceuticals Inc to Discuss The FDA Approval TranscriptNov 02, 2023
- Phathom Pharmaceuticals Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Phathom Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) TranscriptApr 18, 2023
- Phathom Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) TranscriptApr 12, 2022
- Phathom Pharmaceuticals Inc Conference call on the PHALCON-EE Trial Results TranscriptOct 18, 2021
- Phathom Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Phathom Pharmaceuticals Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- Phathom Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMay 21, 2021
- Phathom Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Phathom Pharmaceuticals Inc Phase 3 PHALCON-HP Results Corporate Call TranscriptApr 29, 2021
- Phathom Pharmaceuticals Inc Corporate Analyst Meeting TranscriptDec 14, 2020
- Phathom Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Phathom Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 11, 2020
- Phathom Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMay 21, 2020
Phathom Pharmaceuticals Inc to Discuss The FDA Approval Transcript
Welcome to the Phathom Pharmaceuticals FDA Approval Conference Call. (Operator Instructions) Please be advised that today's call is being recorded. With that, I would like to turn the conference call over to Eric Sciorilli, Head of Investor Relations. Please go ahead.
Thank you, operator. Hello, everyone, and thank you all for joining us this morning to discuss our recent FDA approvals. Just a couple of logistical items before we get started. A recording of today's webcast and presentation can be found under the Events and Presentations section of our corporate website. Also, before we begin, let me remind you that we will be making a number of forward-looking statements throughout today's presentation. These forward-looking statements involve risks and uncertainties, many of which are beyond Phathom's control. Actual results can materially differ from the forward-looking statements, and any such risks can materially adversely affect the business, the results of operations and trading prices for Phathom's common stock. For a detailed description of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)